LEUVEN, Belgium, July 27, 2020 /PRNewswire/ -- Fund+, an investment firm focused on innovative European Life Sciences companies, today announces that it has led the €38 million Series B financing in new portfolio company, Indigo Diabetes (Indigo). Indigo is developing a novel 'invisible'...
from PR Newswire: https://ift.tt/3fYGkZ8
No comments:
Post a Comment